Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
Name | Levothyroxine sodium 75microgram tablets |
BNF code | 0602010V0AABYBY |
Virtual Therapeutic Moiety | Levothyroxine |
Date identifier became valid | 26 May 2021 |
Previous product identifier | 376988009 |
Basis of preferred name | rINN - Recommended International Non-proprietary |
Prescribing status | Valid as a prescribable product |
Sugar free | ✗ |
Gluten free | ✗ |
Preservative free | ✗ |
CFC free | ✗ |
Dose form | Discrete |
Unit dose form size | 1.000 |
Unit dose form units | tablet |
Unit dose unit of measure | tablet |
Virtual Product Ingredient | |
---|---|
Ingredient | Levothyroxine sodium anhydrous |
Basis of pharmaceutical strength | Based on Ingredient Substance |
Strength value numerator | 75.000 |
Strength value numerator unit | microgram |
Ontology Drug Form & Route | |
Form & Route | tablet.oral |
Dose Form | |
Formulation | Oral tablet |
Drug Route | |
Route | Oral |
Controlled Drug Prescribing Information | |
Controlled Drug category | No Controlled Drug Status |
Actual Medicinal Products | |
Levothyroxine sodium 75microgram tablets (A A H Pharmaceuticals Ltd) | |
Levothyroxine sodium 75microgram tablets (Alliance Healthcare (Distribution) Ltd) | |
Levothyroxine sodium 75microgram tablets (Crescent Pharma Ltd) | |
Levothyroxine sodium 75microgram tablets (Medihealth (Northern) Ltd) | |
Levothyroxine sodium 75microgram tablets (Teva UK Ltd) | |
Vencamil 75microgram tablets (Aristo Pharma Ltd) | |
Virtual Medicinal Product Packs | |
Levothyroxine sodium 75microgram tablets 28 tablet |
dm+d data retrieved from TRUD: release NHSBSA_11.3.0_20241125000001, imported on 26th November 2024 at 03:54:16.